Log In
Print
BCIQ
Print
Print this Print this
 

lidocaine/tetracaine (Pliaglis)

  Manage Alerts
Collapse Summary General Information
Company Nuvo Research Inc.
DescriptionPhase-changing topical formulation of lidocaine and tetracaine
Molecular Target Sodium channel voltage-dependent
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationAnesthesia
Indication DetailsNumb the skin before various medical procedures; Produce local anaesthesia on intact skin in adults prior to superficial dermatological procedures
Regulatory Designation

Partner

Galderma S.A.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today